Abstract: Described herein are polymerization catalysts having a structure according to formula (1): wherein is a diimine ligand, A? is a counter anion, and R2 is a fluorinated alkane, alkene or alkyne, a fluorinated aromatic, a fluorinated cycloalkane or cylcoalkene, a fluorinated heteroaromatic, or a fluorinated heterocyclic. Also described herein are polymers having a terminus having a structure according to Formula (3): wherein R2 is a fluorinated alkane, alkene or alkyne, a fluorinated aromatic, a fluorinated cycloalkane or cylcoalkene, a fluorinated heteroaromatic, or a fluorinated heterocyclic.

Abstract: A catalyst having a structure according to Formula (1): wherein R1 and R2 are each independently selected from aliphatic groups, substituted or unsubstituted phenyl groups and silyl groups, or R1 and R2 are bonded together in the form of a cycloalkane, each R3 is hydrogen, an aliphatic group or a halogen, each Ar group is a meta-substituted phenyl group, a para-substituted phenyl group or a meta- and para-substituted phenyl group, M is a transition metal and L1 and L2 are each independently methyl, Cl, Br, NCCH3, DMSO, or L1 and L2 are bonded together in the form of a bidentate ligand.

Abstract: Described herein are polymerization catalysts having a structure according to formula (1): wherein is a diimine ligand, A? is a counter anion, and R2 is a fluorinated alkane, alkene or alkyne, a fluorinated aromatic, a fluorinated cycloalkane or cylcoalkene, a fluorinated heteroaromatic, or a fluorinated heterocyclic. Also described herein are polymers having a terminus having a structure according to Formula (3): wherein R2 is a fluorinated alkane, alkene or alkyne, a fluorinated aromatic, a fluorinated cycloalkane or cylcoalkene, a fluorinated heteroaromatic, or a fluorinated heterocyclic.

Abstract: Nanoparticles and nanonetworks formed of these nanoparticles are provided. Methods for forming such nanoparticles and nanonetworks are also provided, as well as uses of the nanoparticles and/or nanonetworks, including their use for drug delivery.